Search
forResearch 10 of 1000+
- Guidelines on the safety of light‐based home‐use hair removal devices from the European Society for Laser Dermatology
- Ensuring safety in cytotoxic drug preparation: A systematic review of guidelines addressing education for pharmacy professionals
- Discrimination and Proper Use of Polygoni Multiflori Radix, Cynanchi Wilfordii Radix, and Cynanchi Auriculati Radix in Korea: A Descriptive Review
- Chemical Scalp Burn after Hair Coloring—Case Report with Literature Review
- This sector needs laser protection supervisors
- Safety Considerations and Monitoring in Patients Treated with Systemic Medications for Acne
- Hair transplantation: standard guidelines of care.
- Androgen Therapy in Women: A Reappraisal: An Endocrine Society Clinical Practice Guideline
- Endocrine Treatment of Transsexual Persons:An Endocrine Society Clinical Practice Guideline
- International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women
Community 10 of 282
- PP405 2a study was a safety study. Some rational explaining.
- Kintor Pharma Announces Completion of First Patient Enrollment in KX-826 Long-term Safety Phase III Trial for Treatment of AGA
- Efficacy and Safety of Oral Dutasteride 0.5 mg Combined with Oral Minoxidil 2.5 mg for Male Androgenetic Alopecia: A Retrospective Cohort Study
- Kintor long term safety phase 3
- Effectiveness and Safety of Hair Growth Formulation Containing Tectona grandis L.f (Teak) Leaf Extract
- KX-826: Long-Term Safety Results are out!
- 2.5mg dut safety/price/synergy w/topical fin
- How can I safely apply RU58841 whilst I have children in the house?
- How to safely stop topical finasteride?
- Study: You can safely conceive on Dutasteride
Learn
— no results
Try a deeper search in learn →